← Evidence map

ArticleJournal of the American Society of Nephrology : JASN2026

Considerations for Using eGFR Slope as an End Point in Clinical Trials.

Tom Greene et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41091561